Cyrus Harmon
Founder at OLEMA PHARMACEUTICALS, INC.
Net worth: 11 M $ as of 30/03/2024
Profile
Cyrus L.
Harmon is the founder.
He founded Neomorphics, Inc. in 1996, where he served as the Chief Executive Officer from 1996 to 2000.
He also founded Olema Pharmaceuticals, Inc. in 2006 and currently holds the title of Director.
In addition to his founding positions, Dr. Harmon previously worked at Affymetrix, Inc. as the General Manager from 2000 to 2002.
Dr. Harmon obtained his undergraduate and doctorate degrees from the University of California, Berkeley.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 27/03/2024 | 948,311 ( 1.70% ) | 11 M $ | 30/03/2024 |
Cyrus Harmon active positions
| Companies | Position | Start |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Founder | 06/08/2006 |
Former positions of Cyrus Harmon
| Companies | Position | End |
|---|---|---|
| AFFYMETRIX, INC. | Corporate Officer/Principal | 31/12/2001 |
Neomorphics, Inc.
 Neomorphics, Inc. Medical SpecialtiesHealth Technology Neomorphics, Inc. develops, analyzes, and manages genetic information to improve disease. The company is based in Berkeley, CA. The company was founded by Cyrus L. Harmon, Martin G. Reese. Neomorphics was acquired by Affymetrix, Inc., part of Thermo Fisher Scientific, Inc. from April 01, 2016 on October 31, 2000 for $85.92 million. | Chief Executive Officer | 31/12/1999 |
Training of Cyrus Harmon
| University of California, Berkeley | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| OLEMA PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Affymetrix, Inc.
 Affymetrix, Inc. Medical SpecialtiesHealth Technology Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis. The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA. | Health Technology |
Neomorphics, Inc.
Neomorphics, Inc. Medical SpecialtiesHealth Technology Neomorphics, Inc. develops, analyzes, and manages genetic information to improve disease. The company is based in Berkeley, CA. The company was founded by Cyrus L. Harmon, Martin G. Reese. Neomorphics was acquired by Affymetrix, Inc., part of Thermo Fisher Scientific, Inc. from April 01, 2016 on October 31, 2000 for $85.92 million. | Health Technology |
- Stock Market
- Insiders
- Cyrus Harmon
